Diabetes - Page 2

April 2, 2026

New weight-loss pill hits the market, promising 'greater flexibility'

FDA approves Foundayo, a once-daily weight loss pill by Lilly. Clinical trials showed adults lost an average of 27.3 pounds on the highest dose, although there are side effects.

April 1, 2026

Should you microdose Ozempic? Experts are split on risks vs benefits

Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.

March 26, 2026

Why your sugar cravings won’t go away, even if you stop eating sweets

A new study challenges the long-held belief that cutting sweet foods reduces cravings, finding no significant change in sweet tooth preferences or health markers.

March 24, 2026

New stronger weight-loss drug gets green light from FDA: 'Major jump'

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.

March 24, 2026

Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds

Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.

March 20, 2026

Needle-free diabetes management could be on the horizon, study suggests

Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a non-invasive alternative to injections.

March 18, 2026

Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.

March 17, 2026

Specific amount of nightly sleep may lower diabetes risk, researchers find

A large observational study suggests that around seven hours of nightly sleep is associated with lower insulin resistance, while too little or too much sleep may worsen metabolic health.

March 7, 2026

GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest

A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 diabetes compared to other diabetes medications.

March 5, 2026

Ozempic-style drugs could slash complication risks after heart attacks, research suggests

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.